We are live on ! Find out more
BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
1-Year Est. Return 66.05%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+66.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$16.2M
Cap. Flow
-$1.14M
Cap. Flow %
-0.9%
Top 10 Hldgs %
64.99%
Holding
29
New
3
Increased
12
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
ASMB icon
Assembly Biosciences
ASMB
+$4.2M
2
TCDA
Tricida, Inc. Common Stock
TCDA
+$2.75M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.53M
4
EPZM
Epizyme, Inc
EPZM
+$1.49M
5
CALT
Calliditas Therapeutics AB American Depositary Shares
CALT
+$257K

Top Sells

Rank Stock Value
1
TECX
Tectonic Therapeutic
TECX
+$3.94M
2
ADVM
Adverum Biotechnologies
ADVM
+$3.26M
3
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.4M
4
KRRO icon
Korro Bio
KRRO
+$1.5M
5
ZGNX
Zogenix, Inc.
ZGNX
+$755K

Sector Composition

Rank Sector Weight
1 Healthcare 90.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALT
26
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$265K 0.21%
+11,034
New +$257K
AUTL
27
Autolus Therapeutics
AUTL
$548M
$175K 0.14%
15,006
– –
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
– –
-15,601
Closed -$3.26M
TECX
29
Tectonic Therapeutic
TECX
$581M
– –
-18,825
Closed -$3.94M
1
2

Similar funds

WCM
Weld Capital Management New York $98.8M AUM 52.83% 1-Year Est. Return
CCM
Coe Capital Management Highland Park, Illinois $106M AUM 53.24% 1-Year Est. Return
RGM
ROAM Global Management New York $117M AUM
TCM
Taal Capital Management Boston, Massachusetts $122M AUM 50.45% 1-Year Est. Return
RC
Regents Capital Hong Kong $76.8M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
WFWM
Wechter Feldman Wealth Management Parsippany, New Jersey $143M AUM 25.17% 1-Year Est. Return

Burrage Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Burrage Capital Management held 29 positions worth $127M, down 11% from $143M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Burrage Capital Management's Q3 2020 filing shows 3 new, 12 increased, 4 reduced and 2 closed positions. Its largest new stake was Assembly Biosciences: 16,667 shares worth $3.29M. The largest sale was Tectonic Therapeutic, an estimated $3.94M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 96% a quarter earlier.

  • Burrage Capital Management's largest Q3 2020 buy was Assembly Biosciences: 16,667 shares worth $3.29M.
  • Burrage Capital Management added most to Aurinia Pharmaceuticals in Q3 2020, an estimated $1.53M increase.
  • Burrage Capital Management's biggest Q3 2020 reduction was G1 Therapeutics, Inc. Common Stock, cutting an estimated $2.4M.
  • Burrage Capital Management fully exited Tectonic Therapeutic in Q3 2020, selling an estimated $3.94M.
  • Burrage Capital Management's ten largest holdings make up 65% of its $127M portfolio in Q3 2020.
  • Burrage Capital Management opened 3 new positions and closed 2 in Q3 2020.
  • Burrage Capital Management's portfolio value fell 11% quarter-over-quarter to $127M.

Based on Burrage Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.